ArticleEuropean journal of nuclear medicine and molecular imaging2017
Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials?
Sandip Basu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it